Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control

被引:0
|
作者
Mai Ngoc Thi Tran
Khiem Tran Dang
Luong Dai Ly
Nam Quang Tran
机构
[1] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Endocrinology
[2] Endocrinology Clinic,Department of Surgery
[3] My Duc Hospital,Department of Endocrinology
[4] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Endocrinology
[5] Grant and Innovation Center,undefined
[6] University of Medicine and Pharmacy at Ho Chi Minh City,undefined
[7] Vietnam National University,undefined
[8] University Medical Center at Ho Chi Minh City,undefined
关键词
Type 2 diabetes mellitus; Inpatient glycemic control; Basal–bolus insulin therapy; Snack consumption; Glucocorticoid use;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:199 / 207
页数:8
相关论文
共 50 条
  • [31] Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano, D.
    Sieradzki, J.
    Stefanski, A.
    Gentilella, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1425 - 1434
  • [32] Assessment of Glycemic Control and Risk of Hypoglycemia for Two Basal-Bolus Algorithms in Hospitalized Patients with Diabetes Mellitus Type 2
    Mader, Julia K.
    Neubauer, Katharina M.
    Schaupp, Lukas
    Aberer, Felix
    Donsa, Klaus
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas R.
    DIABETES, 2014, 63 : A238 - A239
  • [33] GlucoTab: A Tablet-based Workflow and Decision Support System to Achieve Safe Glycemic Control for Basal-Bolus Insulin Therapy in Hospitalized Patients with Type 2 Diabetes
    Neubauer, Katharina M.
    Mader, Julia K.
    Hoell, Bernhard
    Schaupp, Lukas
    Beck, Peter
    Spat, Stephan
    Augustin, Thomas
    Aberer, Felix
    Plank, Johannes
    Pieber, Thomas R.
    DIABETES, 2014, 63 : A603 - A603
  • [34] Switching from a human insulin basal-bolus regimen to insulin analog basal-bolus therapy with insulin detemir/insulin aspart improves glycemic control and reduces hypoglycemic episodes in patients with type 1 diabetes:: Results from German subgroup of the PREDICTIVE™ study
    Maxeiner, Stephan
    Hansen, Jes B.
    Nauck, Michael
    DIABETES, 2006, 55 : A127 - A127
  • [35] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
    Luedemann, J.
    Merker, L.
    Milek, K.
    Kaiser, M.
    Wilhelm, B.
    DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
  • [36] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [37] Quality Of Life, Hypoglycaemic Symptoms and Treatment Satisfaction in Patients with Type 2 Diabetes Receiving Basal-Bolus Insulin
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    DIABETES MELLITUS, 2015, 18 (04): : 48 - 58
  • [38] Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes
    Hundal, Ripu S.
    Kowalyk, Stephan
    Cases, Jane
    Al-Karadsheh, Amer
    Wakim, Amanda P.
    Doyle, Melissa
    Sink, John H., II
    Spence, Adrienne
    Brewer, Jamie L.
    Nikkel, Carla C.
    DIABETES, 2018, 67
  • [39] Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
    Shimoda, Seiya
    Okubo, Mina
    Koga, Kotaro
    Sekigami, Taiji
    Kawashima, Junji
    Kukidome, Daisuke
    Igata, Motoyuki
    Ishii, Norio
    Shimakawa, Akiko
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Furukawa, Noboru
    Nishida, Kenro
    Araki, Eiichi
    ENDOCRINE JOURNAL, 2015, 62 (02) : 209 - 216
  • [40] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    Kate van Brunt
    Bradley Curtis
    Tibor Ivanyi
    Elemer Balogh
    Corina Chalkiadaki
    Sharon MacLachlan
    David Neasham
    Mireia Raluy-Callado
    Diabetes Therapy, 2016, 7 : 793 - 807